MRD as a Decision Engine: Rethinking Oncology Trial Design from Early Phase to Registration on May 12, 2026 Accelerated Advice Approved Multiple Myeloma Neoplasm, Residual oncology trials Solid Neoplasm trial design United States Food and Drug Administration +
Moderna Accuses FDA of Inconsistent Standards After Refusal to Review mRNA Flu Vaccine Application on February 11, 2026 Moderna mRNA flu refusal-to-file Standard (qualifier) trial design United States Food and Drug Administration Vaccines +
Axsome Plots New Fibromyalgia Trial After FDA Refuses Review of Former Pfizer Candidate on June 11, 2025 Analgesics AXS-14 Axsome Clinical Trials esreboxetine Fibromyalgia File (record) Pfizer refusal trial design United States Food and Drug Administration +